The Intercompany Games held in Barcelona closed with record participation. More than 270 employees from our Siegfried Barberà and Siegfried El Masnou sites participated in these solidarity games that raised more than 24,000 Euros to support projects promoted by the Fundación Josep Carreras contra la Leucemia and the Associació 8000 estels, both focused on the fight against cancer in its different types, and the Asociación Norte Joven in its mission to promote social and labor integration of socially disadvantaged adolescents. The team spirit, healthy competition and, above all, the commitment of all Siegfried employees in such a noble cause made this event a real success once again. Congratulations to unit events for organizing these Intercompany Games and to the associations for the great work they are doing. #teamwork #givingback #strongestteam
Siegfried
Arzneimittelherstellung
Zofingen, Aargau 26.577 Follower:innen
Expect more
Info
Expect more with Siegfried as your preferred partner. Siegfried is a preferred manufacturing and service partner in the global pharmaceutical industry. Our company is looking back on more than 150 years of unmatched quality and combines both chemistry and pharmaceutics under one roof. We develop and manufacture active pharmaceutical ingredients for pharmaceutical clients with R&D programs, related intermediates and controlled substances. Siegfried also offers development and production of finished dosage forms, including sterile fillings. Approximately 3600 dedicated employees in Switzerland, Germany, France, Spain, Malta, China and the USA establish innovative and integrated solutions for our customers that bring a significant added value.
- Website
-
http://www.siegfried.ch
Externer Link zu Siegfried
- Branche
- Arzneimittelherstellung
- Größe
- 1.001–5.000 Beschäftigte
- Hauptsitz
- Zofingen, Aargau
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Gegründet
- 1873
- Spezialgebiete
- Formulation Development, Analytical Development, Solid Dosage Forms, Parenterals (vials, ampoules, cartridges, syringes), Ophtalmics (liquids and semisolids), API, Active Pharmaceutical Ingredient, Exclusive Synthesis, High Potency, Intermediates, Sterile Filling, biologics finished dosage forms und spray drying
Orte
Beschäftigte von Siegfried
Updates
-
Last week we welcomed the University of Applied Sciences Northwestern Switzerland (FHNW) and the Foundation Board at our headquarters to discuss the importance of cooperation between academic and industrial organizations as well as access to specialists and new technologies. Our Siegfried R&D team has had many fruitful collaborations with FHNW in the past, including many Bachelor theses, publications and participation in a patent application.
Wir danken unserer Gastgeberin der Siegfried in Zofingen für die Gelegenheit, die Stiftung FHNW und die Hochschule für Life Sciences FHNW unseren Gästen vorzustellen. Einige Quotes aus den Beiträgen: - "Die Zusammenarbeit zwischen Akademie und Industrie ist sehr wichtig." Dr. Thomas Carl, Head Process R&D & Scale-Up Siegfried AG - "Nicht nur Roche, sondern auch die Zulieferer sind auf qualifizierte Fachkräfte angewiesen." juerg erismann, Präsident der Stiftung FHNW - "Wir brauchen Innovationen, um neue Lösungen und Technologien zu entwickeln." Andreas Koch, Vize-Präsident der Stiftung FHNW - "Unsere Studierenden profitieren am Campus Muttenz von einer ausgezeichneten Infrastruktur." Prof. Dr. Falko Schlottig, Direktor der Hochschule für Life Sciences FHNW - "Wir danken der Stiftung FHNW für die Unterstützung bei der Erforschung der mRNA-Technologie." Prof. Dr. Oya Tagit, Team Leader BioInterfaces am Institute for Chemistry and Bioanalytics - "Der Studiengang Chemie an der Hochschule für Life Sciences FHNW hat mich überzeugt: Die Labore sind auf einem tollen Stand." Livia Müller, Studentin Mehr dazu in der Präsentation.
-
EGS Beteiligungen AG exercised its right to convert one of the convertible bonds issued in December 2020 with a coupon of 0.650% and a nominal value of CHF 40m into shares. Read the press release to learn more: https://lnkd.in/dJYHwrU9 #announcement #pressrelease #CDMO #bonds
-
Siegfried to acquire a CDMO specialized in early-phase development and manufacturing services in Grafton, Wisconsin (US). The new site is set to strengthen Siegfried's customer offering for Drug Substances in terms of capabilities and geography. Read more in the press release: https://lnkd.in/dzXDAVTq #announcement #pressrelease #growth #earlyphasedevelopment #CDMO
Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Drug Substances service offering - Siegfried
https://www.siegfried.ch
-
What is your company doing to meet the ever-increasing expectations of investors, shareholders and customers in relation to sustainability targets while complying with important political initiatives such as the European Green Deal? This was a key topic at the recent #DCAT Sustainability Summit roundtable where Luca Dalla Torre, Siegfried General Counsel and Chairman of the Sustainability Board, took part. Alongside industry experts, Annette Quincy-Garg, Nelleke Barning, and moderator Kelsey Achenbach, they discussed insights into metrics, common reporting standards and key requirements for assessing a company's environmental and sustainability performance. #bio #pharma #biopharma #pharmaceutical #sustainability #networking #event #dcat
-
Meet Patrick, who joined our Siegfried Hameln site after completing his studies. Throughout his time with Siegfried, he continues to learn and be challenged everyday. Want to learn more about Patrick's experience? Check out his full story https://lnkd.in/gYtVrFW8 #EmployeeAmbassador #Teamwork #ContinuousLearning #CareerGrowth #FinanceAndControlling
-
Our Siegfried sites in Barcelona once again participate in the Intercompany Games, a solidarity business Olympics organized by unit events that aims to promote teamwork and solidarity between companies using sport as powerful tool for communication and cohesion. The profits will go to the Fundación Josep Carreras to continue the fight against leukemia, as well as to the 8.000 estels Association to support research into childhood cancer. In this 18th edition, the record number of participants was broken with more than 2700 people taking part in more than 20 different disciplines. The competition began on 1 May and will end on 30 May. During these weeks, more than 270 #Siegfriedians from Siegfried Barberà and Siegfried El Masnou will participate as #strongestteam. All information about the Intercompany Games can be found here: https://lnkd.in/ddrHycKw #intercompanygames #strongestteam #solidarity #SiegfriedBarbera #SiegfriedElMasnou
-
Biopharmaceuticals have complex molecular structures, and developing and running the fill & finish processes to manufacture the dosage forms are challenging. Read Marianne Spaene's blog on what to look for when selecting a fill & finish partner: https://lnkd.in/dnuNb24Y #expertise #CDMOpartner #biologics #fillandfinish #blog
-
Meet Paco, a dedicated member of our team at the Siegfried El Masnou site for more than 26 years! Throughout his journey, he has embraced various roles and found a community among his colleagues. Curious to learn more about Paco's inspiring journey? Check out his full story https://lnkd.in/d2tsJ_Mr #EmployeeAmbassador #Dedication #Teamwork #ContinuousLearning #CareerGrowth
-
We are seeking Lab Technicians and Chemists specialized in analytical development to join our state-of-the-art Research and Development Center opening in Evionnaz, Switzerland. With an investment of nearly CHF 25 million, and a dynamic team of over 100 experts, this new facility significantly increases Siegfried's R&D capacities. If you're looking to advance your career while making an impact on the lives of millions of patients worldwide, Siegfried Evionnaz offers a unique setting for passionate professionals to flourish. https://lnkd.in/dRUainEW